United States · Venture startup

Who invested in INDIGO Biosciences

2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 31 Oct 2026

$782Kraised across 2 rounds since 2010, from 2 sources

$100KVenture$682KVenture
Latest round
Venture, $682KOct 2011
Step-upi
6.8×
Investors
0
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011
$100KVenture$682KVenture
First round
Venture, $100K
Sept 2010
Biggest round
$682K
Venture · Oct 2011
Between rounds
13 months
from the last two

The rounds

  1. Oct 2011
    Venture$682K

    No investor was named in the report.

    Reported by sec.govSEC filing: $682K sold, first sale Oct 2011

  2. Sept 2010
    Venture$100K

    No investor was named in the report.

    From a historical funding recordSEC filing: $100K sold, first sale Aug 2010

Also claim to have backed them

This firm lists INDIGO Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Keiretsu CapitalVC firmPer its own site

Quick answers about INDIGO Biosciences

How much has INDIGO Biosciences raised?

INDIGO Biosciences has raised $782K across 2 rounds since 2010.

When did INDIGO Biosciences last raise?

INDIGO Biosciences's most recent round was a Venture of $682K in Oct 2011.

What was INDIGO Biosciences's biggest round?

Its most recent round, $682K in Oct 2011, is also its largest on record.

What stage is INDIGO Biosciences at?

INDIGO Biosciences's latest named round is a Venture, in Oct 2011.

Where is INDIGO Biosciences based?

INDIGO Biosciences is based in the United States.

Companies like INDIGO Biosciences

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.